Provided by Tiger Fintech (Singapore) Pte. Ltd.

Day One Biopharmaceuticals Inc.

6.55
-0.2500-3.68%
Volume:298.35K
Turnover:1.99M
Market Cap:663.92M
PE:-9.22
High:6.81
Open:6.80
Low:6.53
Close:6.80
Loading ...
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities